Fourth-Quarter and Full-Year 2019 Orphan and Rheumatology Segment Results
GAAP to Non-GAAP Reconciliation
GAAP and Non-GAAP Earnings (Loss) Per Share - Basic and Diluted - Three and Twelve Months Ended December 31
$ in thousands, except share and per share data
Non-GAAP Earnings Per Share:
Weighted average ordinary shares - Basic
Non-GAAP Earnings Per Share - Basic:
Three Months Ended December 31,
2019
2018
Twelve Months Ended December 31,
2019
2018
187,421,561
168,126,924
182,930,109
166,155,405
GAAP earnings (loss) per share - Basic
Non-GAAP adjustments
Non-GAAP earnings per share - Basic
$
3.16
$
0.60
$
3.13
$
(0.23)
(2.54)
0.09
(1.00)
2.12
$
0.62
$
0.69
$
2.13 $
1.89
Non-GAAP Net Income
$
Effect of assumed conversion of Exchangeable Senior Notes, net of tax
Numerator non-GAAP Net Income
$
116,580 $
1,875
118,455
116,767
$
$
116,767
$
390,218 $
7,500
397,718
314,651
$
314,651
Weighted average ordinary shares - Diluted
Weighted average ordinary shares - Basic
Ordinary share equivalents
Denominator - Weighted average ordinary shares - Diluted
187,421,561
23,532,018
210,953,579
168,126,924
6,103,787
174,230,711
182,930,109
22,294,112
205,224,221
166,155,405
5,393,514
171,548,919
Non-GAAP Earnings Per Share - Diluted
GAAP earnings (loss) per share - Diluted
$
2.84
$
0.58
2.90
$
Non-GAAP adjustments
(2.28)
0.09
(0.96)
(0.23)
2.12
Diluted earnings per share effect of ordinary share equivalents
Non-GAAP earnings per share - Diluted
(0.06)
$
0.56
$
0.67
$
1.94
$
1.83
HORIZON
48View entire presentation